Jay Flatley, Chief Executive Officer at Illumina, Inc. (NASDAQ:ILMN), completed a stock sale of 30,000 shares yesterday. He unloaded the Common Stock directly, via several smaller dispositions, and for weighted average sales prices ranging between $171.22 and $183.65 per share. Furthermore, the insider also exercised his use of non-qualified stock options in order to complete the transaction. Following the disposition, Flatley now holds a total of 381,262 company shares to his name.
This week also reported a second insider stock sale at the $21.9 billion market cap medical equipment manufacturer. The talk is of company Director Daniel Bradbury, who unloaded 2,100 shares of Common Stock for a weighted average sales price ranging between $176.36 and $179.90 per share. The insider also exercised his use of stock options.
However, in spite of the regular stock dispositions at Illumina over the past quarter, hedge funds have shown confidence in the firm. In fact, this quarter showed a new shareholder position at the hand of Paul Ruddock and Steve Heinz’s Landsdowne Partners, which recently acquired nearly 1.2 million company shares, worth $178.3 million.